New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tandem Diabetes Care, Inc.
TNDM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Medical - Devices

Next Earning date - 06 Nov 2024

2B

Medical - Devices

Next Earning date - 06 Nov 2024

34.81USD
Shape-2.69 ( -7.17%)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

29%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

35%

Quote Panel

Shape
Updated October 18, 2024
1W -6.83 % 1M -21.69 % 3M -20.27 % 1Y 78.42 %

Key Metrics

Shape
  • Market Cap

    2.28B


  • Shares Outstanding

    65.46M


  • Share in Float

    64.95M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    34.81


  • Average Volume

    1.41M


  • Beta

    1.335


  • Range

    13.82-53.69


  • Industry

    Medical - Devices


  • Website

    https://www.tandemdiabetes.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.86x

P/S Ratio

9.67x

P/B Ratio

1.6

Debt/Equity

-17.1%

Net Margin

$-2.1

EPS

How TNDM compares to sector?

P/E Ratio

Relative Strength

Shape

TNDM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$989M

Shape345%

2025-Revenue

$1.18

Shape-151%

2025-EPS

$45M

Shape-68%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

initialise

Previous: Not converted

2024-10-04

Now: Neutral

RBC Capital

initialise

Previous: Not converted

2024-10-02

Now: Outperform

Morgan Stanley

initialise

Previous: Not converted

2024-08-22

Now: Equal-Weight

Canaccord Genuity

initialise

Previous: Not converted

2024-08-08

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.27
vs 0.09

Q4.22

arrow
arrow

N/A

-0.01
vs 0.16

Q1.23

arrow
arrow

N/A

-0.63
vs -0.23

Q2.23

arrow
arrow

N/A

-0.30
vs -0.24

Q3.23

arrow
arrow

N/A

-0.38
vs -0.27

Q4.23

arrow
arrow

N/A

-0.27
vs -0.01

Q1.24

arrow
arrow

N/A

-0.63
vs -0.63

Q2.24

arrow
arrow

N/A

-0.47
vs -0.30

Q3.24

arrow
arrow

N/A

-0.41
vs -0.38

Q4.24

arrow
arrow

N/A

-0.19
vs -0.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

204.5M  vs 179.6M

Q4.22

arrow
arrow

+5%

220.5M  vs 210M

Q1.23

arrow
arrow

-4%

169.4M  vs 175.9M

Q2.23

arrow
arrow

-2%

195.9M  vs 200.3M

Q3.23

arrow
arrow

-9%

185.6M  vs 204.5M

Q4.23

arrow
arrow

-11%

196.8M  vs 220.5M

Q1.24

arrow
arrow

+13%

191.7M  vs 169.4M

Q2.24

arrow
arrow

+13%

221.9M  vs 195.9M

Q3.24

arrow
arrow

+20%

223.7M  vs 185.6M

Q4.24

arrow
arrow

+28%

251.7M  vs 196.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.03

Q4.22

arrow
arrow

-4%

-0.04
vs -0.12

Q1.23

arrow
arrow

-37%

-0.37
vs -0.04

Q2.23

arrow
arrow

-11%

-0.11
vs -0.37

Q3.23

arrow
arrow

-10%

-0.10
vs -0.11

Q4.23

arrow
arrow

-10%

-0.10
vs -0.10

Q1.24

arrow
arrow

-18%

-0.18
vs -0.10

Q2.24

arrow
arrow

-13%

-0.13
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

310

310
vs 340

-9%

Q4.22

arrow
arrow

316

316
vs 310

2%

Q1.23

arrow
arrow

281

281
vs 316

-11%

Q2.23

arrow
arrow

259

259
vs 281

-8%

Q3.23

arrow
arrow

239

239
vs 259

-8%

Q4.23

arrow
arrow

282

282
vs 239

18%

Q1.24

arrow
arrow

306

306
vs 282

9%

Q2.24

arrow
arrow

334

334
vs 306

9%

Earnings Growth

Latest News